Need Help With This Assignment?

Let Our Team of Professional Writers Write a PLAGIARISM-FREE Paper for You!

SUBMIT YOUR ASSIGNMENT

Essay, Nursing, Pages: 2

Effective Treatments for Pediatric PTSD

Effective Treatments for Pediatric PTSD

Posttraumatic stress disorder (PTSD) diagnosis in children necessitates a multimodal treatment strategy. This paper advocates for sertraline, which is pharmacological and approved by the FDA for PTSD, Prazosin, which is pharmacological but not FDA-approved for PTSD, and trauma-focused cognitive behavioral therapy (TF-CBT), which does not involve the administration of drugs. The treatment option depends on the risk assessment, the plan, and carrying out studies to ensure patient outcomes would be effective and safe: Effective Treatments for Pediatric PTSD.

FDA-Approved Medication: Sertraline

Sertraline hydrochloride (Zoloft) is a selective serotonin reuptake inhibitor (SSRI) with the approval of the FDA for the management of PTSD in children. SSRIs act at the serotonin receptor regions and hence abolish related symptoms, including anxiousness, depression, and hyperarousal. Literature reviews have also identified the effectiveness of sertraline in decreasing PTSD symptoms and improving affect regulation in children and adolescents with the condition (Singh & Saadabadi, 2023).

Risks and Benefits

Sertraline has several advantages, such as better mood control, reduced anxiety, and better daily functioning. However, it is also associated with side effects like gastrointestinal symptoms, headaches, and increased agitation. The most severe risk is that of increased suicidal ideation, particularly in young patients, for which healthcare practitioners should be vigilant (Chu & Wadhwa, 2023).

Off-Label Medication: Prazosin

Prazosin is an alpha-1 adrenergic receptor antagonist usually used for childhood PTSD since it is effective for PTSD nightmares and sleep impairments. Accordingly, prazosin minimizes hyperarousal and enhances sleep since it inhibits the effects of norepinephrine. Research has shown that it has the potential to help reduce PTSD-related nightmares and enhance sleep health in children and adolescents (Basquez & Pippin, 2023).

Risks and Benefits

The benefits of prazosin include the diminishment of nightmares, improvement of sleep, and less severity of PTSD symptoms. Its side effects are, however, seen in hypotension, dizziness, fatigue, and sometimes fainting. Due to the possibility of children developing orthostatic hypotension, the dose should be given carefully and gradually ascending, starting from a very low dose and depending on the child’s response (Basquez & Pippin, 2023).

Nonpharmacological Intervention: TF-CBT

Trauma-focused cognitive behavioral therapy is the gold standard for treating PTSD in children and adolescents. This outstanding, highly organized approach combines cognitive-behavioral concepts, gradual exposure, and coping statements for treating traumatized children to work through their traumatic experiences and modify their reactions. TF-CBT reduces PTSD symptoms and improves regulatory function and overall vocational outcome (Thomas et al., 2020).

Risk Assessment for Treatment Decision-Making

Risk assessment is important in managing PTSD in children for factors such as severity, further conditions, prior medication experience, and personal circumstances. Sertraline is an FDA-approved SSRI for moderate to severe PTSD but has to be prescribed cautiously due to side effects such as agitation and suicidal thoughts.

Prazosin is not FDA-approved for PTSD but is effective for the treatment of nightmares; however, it has the side effects of hypotension and dizziness and needs dose adjustments. For mild and moderate PTSD, TF-CBT is the first-line therapy because it bypasses drug interventions. In some instances, patients may require both TF-CBT and pharmacotherapy involving sertraline or prazosin to achieve the best results.

Clinical Practice Guidelines and Justification of Recommendations

Clinical guidelines support a multimodal approach to treating PTSD in children and adolescents. The treatment guidelines of the American Academy of Child and Adolescent Psychiatry state that TF-CBT should be considered first-line therapy, after which pharmacotherapy is prescribed (Wheeler, 2020). If the symptoms continue or are severe, then SSRIs like sertraline should be used because it gives an effective reduction to PTSD symptoms. Although prazosin is not included in any official guidelines, it is efficient in the off-label use for PTSD, especially in treating nightmares and sleep disturbances (American Psychiatric Association, 2022).

Given these guidelines, the recommended treatment plan follows a stepwise approach: initiate TF-CBT as the primary intervention for all children with PTSD; if symptoms persist or PTSD is severe, introduce sertraline with close monitoring for side effects; and if nightmares or sleep disturbances remain problematic, consider prazosin with careful titration.

Conclusion

PTSD in children should be approached systematically and according to the latest academic findings. For mild cases, the recommended treatment is TF-CBT; in cases where the symptoms are more severe, the treatment is with sertraline. It is important to point out that even though it is not authorized to treat PTSD, prazosin brings relief to those with nightmares. The approach allows for maximum therapeutic efficacy and the excluding of dangerous side effects since it is patient-specific, risk-based, and patient-oriented.

References

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Association.

Basquez, R., & Pippin, M. M. (2023, August 17). Prazosin. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK555959/

Chu, A., & Wadhwa, R. (2023). Selective serotonin reuptake inhibitors. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554406/

Singh, H. K., & Saadabadi, A. (2023). Sertraline. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK547689/

Thomas, F. C., Puente‐Duran, S., Mutschler, C., & Monson, C. M. (2020). Trauma‐focused cognitive behavioral therapy for children and youth in low and middle‐income countries: A systematic review. Child and Adolescent Mental Health, 27(2). https://doi.org/10.1111/camh.12435

Wheeler, K. (Ed.). (2020). Psychotherapy for the advanced-practice nurse: A how-to guide for evidence-based practice (2nd ed.). Springer Publishing Company.

ORDER A PLAGIARISM-FREE PAPER HERE

We’ll write everything from scratch

Question

Off-label prescribing is when a physician gives you a drug that the U.S. Food and Drug Administration (FDA) has approved to treat a condition different than your condition. This practice is legal and common. In fact, one in five prescriptions written today are for off-label use.

—Agency for Healthcare Research and Quality

Psychotropic drugs are commonly used for children and adolescents to treat mental health disorders, yet many of these drugs are not FDA approved for use in these populations. Thus, their use is considered “off-label,” and it is often up to the best judgment of the prescribing clinician. As a PMHNP, you will need to apply the best available information and research on pharmacological treatments for children in order to safely and effectively treat child and adolescent patients. Sometimes this will come in the form of formal studies and approvals for drugs in children.

Other times you may need to extrapolate from research or treatment guidelines on drugs in adults. Each individual patient case will need to be considered independently and each treatment considered from a risk assessment standpoint. What psychotherapeutic approach might be indicated as an initial treatment? What are the potential side effects of a particular drug?

For this Assignment, you consider these questions and others as you explore FDA-approved (“on label”) pharmacological treatments, non-FDA-approved (“off-label”) pharmacological treatments, and nonpharmacological treatments for disorders in children and adolescents.

Reference:

TO PREPARE

  • Your Instructor will assign a specific disorder for you to research for this Assignment.
  • Use the Walden library to research evidence-based treatments for your assigned disorder in children and adolescents. You will need to recommend
    • one FDA-approved drug,
    • one off-label drug, and
    • one nonpharmacological intervention for treating this disorder in children and adolescents.

THE ASSIGNMENT (1–2 PAGES)

  • Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating your assigned disorder in children and adolescents.
  • Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?
  • Explain whether clinical practice guidelines exist for this disorder and, if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.
  • Support your reasoning with at least three scholarly resources, one each on the FDA-approved drug, the off-label, and a non-medication intervention for the disorder. Attach the PDFs of your sources.

BY DAY 7 OF WEEK 3
Submit your Assignment.

SUBMISSION INFORMATION
Before submitting your final assignment, you can check your draft for authenticity. To check your draft, access the Turnitin Drafts from the Start Here area.

  • To submit your completed assignment, save your Assignment as WK3Assgn1+last name+first initial.
  • Then, click on Start Assignment near the top of the page.
  • Next, click on Upload File and select Submit Assignment for review.

Resources;

Client’s Notes:
  • Hello my assigned specific disorder is Posttraumatic Stress Disorder